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Abstract:
Raman spectroscopy is a branch of vibration spectroscopy which is capable of probing the chemical
composition of materials. Recent advances in Raman microscopy have added significantly to the range
of applications which now extend from medical diagnostics to exploring interfaces between biological
organisms and nanomaterials. In this review, Raman is introduced in a general context, highlighting
some of the areas in which the technique has found success in the past, as well as some of the potential
benefits it offers over other analytical modalities. The subset of Raman techniques which specifically

probe the nanoscale, namely Surface Enhanced and Tip Enhanced Raman Spectroscopy, will be
described and specific applications relevant to nanomedical applications will be reviewed. Progress in
the use of traditional label-free Raman applied to investigation of nanoscale interactions will be
described, and recent developments in Coherent Anti-Stokes Raman Scattering will be explored,
particularly applications to biomedical and nanomedical fields.
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Introduction

Nanomedicine can be defined as the medical applications of nanotechnology[1], ranging from the use of
nanomaterials in regenerative medicine, drug delivery strategies, medical diagnostics and therapeutics
and including potential negative impacts of nanomaterials to human health, commonly encompassed
under the term Nanotoxicology. In the context of this review article, nanomedicine is viewed from the
perspective of how Raman spectroscopy (and its variants) can be used in the assessment of the
beneficial as well as the potential negative impacts of Nanomaterials on human health. Nanomaterials
have already found uses in a wide range of applications, including anti-microbial paint coatings[2],
textile finishing[3], and novel applications in the electronics industry[4]. Notably, biomedical
applications are rapidly emerging, ranging from nanoparticle coated stents for angioplasty[5], contrast
agents for diagnostic imaging[6,7] and also potential drug and gene delivery vehicles[8–10]. These
applications are largely dependent on the particular characteristics which nanomaterials and
nanoparticles possess. These include properties such as increased surface to mass ratio which in turn
results in an increase in surface reactivity, while novel optical properties associated with some classes of
nanoparticles are important for applications in theranostic imaging and subsequent monitoring of drug
delivery. However, whilst these technologies show promise, it is important to be able to visualise how
the materials behave in situ, and particularly in the biological context, to be able to characterise their
interactions and toxicological effects, be they in-vitro or in-vivo. While it has been highlighted that
comprehensive characterisation of the physico-chemical properties of nanoparticles is imperative,
changes to these properties, such as aggregation state and effective surface chemistry, can play a critical
role in their modes of interaction and action [11]. Equally, to understand the modes of action and
optimise efficacies, monitoring and understanding changes to the biological environment is critical, not
only on a cellular level but also when considering the systemic responses.

Considering the system as a whole, one must be able to track a particle or material from initial
exposure or administration through to the site of action and on to assimilation, degradation or
excretion. At each step in this process, one must be able to access and visualise the efficacy by which the
particles can overcome certain barriers to successful administration. These can vary from the route of
exposure, assessing whether the particle causes toxicity, particle retention (e.g. via the enhanced
permeability and retention (EPR) effect), or removal for circulation via uptake by the reticuloendothelial
system (RES), accumulation of the nanoparticles over time, non-specific interactions, the efficacy with
which the particle reaches its desired location etc..
Ideally, what is required is a method which can successfully characterise these processes, firstly
in fundamental in vitro cytological and ex-vivo histological studies and ultimately in more realistic in-vivo
applications. This method should be capable of identifying the particle or material of interest while
simultaneously being able to access the surrounding environment while measuring the efficacy of the
probe or nanocarrier and/or the physiological response of the organism.
There exists a large range of analytical methods which can be used in the classification and
characterisation of nanomaterials. These include scanning and transmission electron microscopy (SEM
and TEM), atomic force microscopy (AFM), other label free optical methods such as differential
interference contrast (DIC) and dark field microscopy and fluorescent microscopy methods based on
intrinsic nanoparticle or external label fluorescence, to name but a few. However, these methods are
not without certain drawbacks which limit to some extent their applicability and effectiveness.
Firstly, both AFM and SEM can be considered as primarily surface sensitive techniques, while,
when TEM is coupled with serial sectioning and ultra-microtomy, it has been used for 3D reconstructions
and tomography[12,13]. However, these processes are time consuming, costly and laborious. In
addition, EM requires a particle to have contrasting electron density compared to its environment to

allow for a particle to be visualised, which renders it ineffective for many “softer” polymeric
nanoparticles. EM does not allow live cells to be imaged and, as it requires extensive sample processing,
it provides only a limited scope for rapid or routine investigation of nanomaterials in-vitro. What EM and
AFM do provide is the capability of imaging beyond the optical diffraction limit. More recently
developed optical based methods, so-called super resolution microscopy, have become available that
allow for imaging beyond this limit [14–16]. However, their use has been limited in the field of
nanomedical sciences as of yet.
In contrast, standard fluorescent based microscopy has been used extensively in nanoparticle
studies[16–19]. Confocal Laser Scanning (fluorescence) Microscopy (CLSM) has become a standard in
the toolbox of techniques for in vitro cytommetry [21]. Although the technique is limited in resolution to
hundreds of nanometers, it can potentially detect fluorescence emission from, and therefore the
location of, individual nanoparticles. Penetration depths in vivo can be extended through two photon
excitation techniques and/or NIR fluorophores [22,23]. In the visible region, a range of fluorescent
assays and labels are commercially available to probe a range of physiological processes in vitro, such as
lyso and mitotracker used for labelling lysosomes and mitochondria [101] Intrinsically fluorescent
nanoparticles such as inorganic semiconductor quantum dots have been developed for similar
applications [102] and surface functionalisation of these types of materials has contributed to
understanding the dependence of uptake and intracellular trafficking on surface chemistry [24]. Many
similar studies have been performed with fluorescently labelled nanoparticles [25,26] which are
commercially available in a range of sizes and surface functionalities. However, not all nanoparticles can
be easily fluorescently labelled. Furthermore, it is not clear that the transport mechanisms of smaller
nanoparticles, fluorescently labelled with anionic moieties, are the same as their unlabelled
counterparts [27]. Critically, there have been reports that labelled nanoparticles can release the dye into
the surrounding biological environment, and so the distribution of fluorescence within the cell does not

necessarily represent the presence or subcellular distribution of the nanoparticles[28–30]. Other label
free optical microscopy techniques are also limited by the type of particle which can be visualised i.e.
only metal based particles are effective for dark field and DIC microscopy [31].
Raman spectroscopy has been proposed as a method for monitoring nanomaterials in biological
systems, as it potentially provides a label free, non-invasive probe of the nanoparticle itself, the local
environment and the physiology of the organism [32] . Over the past decade, Raman spectroscopy has
been applied to a range of biomedical areas, including cancer diagnostics[33], toxicity studies[34],
atherosclerosis[35] and investigation of skin[36,37]. Importantly, what Raman provides is not just a
method for differentiation between a diseased and non-diseased state, it is based on characterisation of
the (bio) chemical nature of a sample, based on the characteristic vibrations of the molecular bonds of
the constituent components. Raman is a form of vibrational spectroscopy, which in itself is a subset of a
more general umbrella term of spectroscopy. The vibrations are characteristic of the molecular
structure and, in polyatomic molecules, give rise to a spectroscopic “fingerprint”. The spectrum of
vibrational energies can thus be employed to characterise a molecular structure, or changes to it due to
the local environment or external factors. The Raman spectrum is thus a truly label free signature of the
nanoparticle. Vibrational energies typically fall in the mid Infrared (IR) region of the electromagnetic
spectrum and are quite commonly probed using IR absorption spectroscopy. Raman in many ways can
be viewed as a complementary technique to IR spectroscopy; whereas IR involves absorption of
radiation, Raman is an inelastic scattering technique whereby the incident radiation couples with the
vibrating polarisation of the molecule and thus generates or annihilates a vibration. For a vibration to be
active in IR spectroscopy, a change in dipole is required, whereas to be Raman active, a change in
polarisability is required. As a rule of thumb, vibrations of asymmetric, polar bonds tend to be strong in
IR spectra, whereas Raman is particularly suitable as a probe of symmetric, nonpolar groups.
Importantly, this results in the O-H bonds of water being strong absorbers in IR spectroscopy, whereas

they are relatively weak Raman scatterers. This allows for samples to be investigated in an aqueous
environment and thus the technique of Raman spectroscopy more readily lends itself to live cell in
vitro[38] or in vivo[39] measurement. As the vibrational spectrum is measured as a frequency (or
energy) shift from that of the incident radiation, Raman spectroscopy can be performed across the UV,
visible or near infrared spectral regions, and thus can benefit from the technologies available and
advances made for confocal optical microscopy.
A number of variants which are based around the physical principal of Raman spectroscopy
exist. Spontaneous Raman can take the form of Stokes Raman scattering and anti-Stokes Raman
scattering, the former resulting from the creation of a vibration in a material, characterised by a
decrease in the incident photon energy (frequency), the latter from the annihilation of vibration,
characterised by an increase in the incident photon energy. If the incident radiation is resonant with an
electronic absorption of the analyte, the Raman signal can be resonantly enhanced by several orders of
magnitude. The use of Resonant Raman Spectroscopy (RRS) in biomedical systems has been limited,
however, due to associated photochemical degradation phenomena and the generation of fluorescence
which can swamp the Raman signal of the overall sample.
Other variants of these two techniques with increased sensitivities for more molecularly

specific characterisation have been developed. These include resonant Raman spectroscopy, coherent
anti Stokes Raman spectroscopy (CARS), tip enhanced Raman spectroscopy (TERS) and surface enhanced
Raman spectroscopy (SERS). The majority of these techniques have been applied to nanomedical
applications; however, two of these methods deal inherently with the nanoscale, namely TERS and SERS.
Although Raman is fundamentally an optical technique and is thus similar to confocal optical
microscopy, limited to spatial resolution of the order of hundreds of nanometres, nanometre resolution
can be obtained through localised enhancement processes. This localised enhancement led to the initial

interest in the prospect of the use of Raman spectroscopy to probe the specific environment of the
nanoparticle.
This article will outline the applications of the various Raman spectroscopy based technique in the broad
area of Nanomedicine. As they are nano-specific, the use of SERS and TERS techniques will be presented
initially, while the increasing interest in the use of truly label free spontaneous Raman and Coherent
Anti-Stokes Raman Spectroscopy (CARS) in nanomedical applications will then be explored. In Raman
spectroscopy, the sensitivity, spatial resolution and penetration depth and required scan rates depend
on technique employed, resonance conditions and even the instrumental set-up (microscope objective,
grating, laser power). In the respective section describing each modality, examples of the state of the art
in nanomedical applications are provided. The future perspectives attempts to address routes beyond
the current state of the art. A more detailed description of the historical origin and basic principles of
the Raman scattering process can be found in numerous excellent text books[40–44] and review
articles[45–47]. A comparison of Raman and IR spectroscopies for biomedical applications can be found
in [48].

SERS
The phenomenon of surface enhanced Raman spectroscopy was described as early as 1974
[49,50], and is understood to arise from a localised increase in the coupling between the
electromagnetic field of the incident radiation and the polarisation of the analyte in the presence of
optically induced surface plasmons on a metal surface. Increases of Raman intensities as high as 1010
have been reported [51], although the spatial range of enhancement is only of the order of tens of

nanometers. The enhancement process can be achieved using a number of substrates including
roughened metallic surfaces, structured metal arrays and specially imprinted surfaces.
Notably, the SERS effect can be induced through the use of metallic nanoparticles and nano
colloid aggregates. SERS is a direct enhancement of the Raman signal and in the case of nanoparticles
this occurs in the immediately surrounding local vicinity. The true principal that governs SERS
enhancement is not fully understood, although the effect has largely been attributed to an electronic
enhancement due to local fields generated by surface plasmon resonances at the metal surface.
Alternatively, the enhancement has been attributed to a charge transfer process between the analyte
and the surface, although it is probable that the processes act in tandem[52]. The technique of SERS in a
biomedical context is reviewed in greater detail in the following papers[53–55].
Nanoparticles and aggregates which are used for SERS enhancement typically consist of a
metallic nanoparticle, most commonly gold and silver. Quite often, these particles are subsequently
modified via surface functionalisation which can include targeting moieties designed for specific
applications, especially as nanosensors. The particle may also be labelled with a Raman reporter moiety
which allows for identification of the particle in the biological milieu. Using these particles, it has thus
been possible to apply SERS to a number of biological scenarios, which include diagnostic studies in
vitro, ex-vivo[56,57] and in-vivo[58,59] , novel bio assays[60–62] as well as cellular studies.
SERS has been proposed as a method for understanding how nanomaterials behave in a cellular
environment, important in the study of the fundamental interactions of nanoparticles in the context of
toxicology, drug delivery or contrast agents for diagnostics. In 2003, Kneipp et al. proposed that by
using SERS it would be possible to probe the chemical nature of the subcellular environment and the
intracellular distribution of biomolecules. This work was extended by incorporation of Raman reporters
which allowed for localisation of the SERS probe within the cell, leading to chemical probing of sub

cellular nanostructures[63–66]. For example, in 2010, the group showed how a SERS nanosensor was
capable of investigating pH changes in a cell throughout the stages of the endocytic pathway of the
nanoparticle probe. The study was based on changes in the pH of the local environment in different
cellular organelles which can be monitored via changes in the pH sensitive nanoprobe over time[67].
Other cellular studies have also investigated the possible use of SERS in the investigation of cell
surface receptors associated with cancer. In one such study, Kong et al 2012 used organometallic SERS
active nanoparticles which were targeted to live cells expressing the EGFR (epidermal growth factor
receptor). The SERS nanoparticles were shown to be capable of specific targeting to the cell surface and
offered increased sensitivity in comparison to other imaging modalities[68]. Figure 1 a-e, shows oral
squamous cell carcinoma (OSCC) cells expressing the epidermal growth factor receptor (EGFR), c and e
show the SERS image generated by CO at 2030cm-1 and protein at 1600cm-1 respectively. The targeting is
verified in Figure 1 f – j in a non-EGFR expressing cell line SKOV3 (ovarian carcinoma) and in Figure 1 k-p
by blockage of the EGFR using an EGFR antibody.

Figure 1 shows (a, f, k) the brightfield image, (b, g, l) the darkfield image of the nanoparticles, c, h, m)
the SERS image of CO at 2030cm-1, (d, I, o) merged SERS and brightfield, and (e, j, p) the SERS image
generated using the protein band at 1600cm1. a – e shows OSCC cells, f – g SKOV3 cells not expressing
EGFR and k – p OSCC cells treated with anti-EGFR. Reproduced from [68]
Another demonstrated application of SERS in is the analysis of human serum. Lin et al., in 2011,
demonstrated the power of SERS coupled with multivariate analysis to distinguish in a non invasive way
between patients previously diagnosed with colorectal cancer and control patients with 100% diagnostic
sensitivity and specificity[69].
In-vivo SERS is also possible, and has been demonstrated as a potential labelling method for a
number of applications. SERS has been used in-vivo to investigate how enhancement of the Raman
signal can be used as a method for tumour detection. Qian et al. showed how EGFR targeting PEGylated

gold nanoparticles labelled with a Raman reporter where capable of >200 times greater signal
generation in the infrared compared to that of near infrared fluorescent quantum dots, which allowed
for the possible identification of small tumours at penetration depths of ~ 1-2cm[58]. Other in-vivo
applications of SERS have also been explored, including an in-vivo study of inflammation in mice[70],
demonstrating improvements over fluorescent based methods. SERS has also been shown to be capable
of single molecule detection in-vitro, a sensitivity which sets it apart from spontaneous Raman
spectroscopy [71].
More complex Raman based investigations have also taken advantage of the surface enhancement
process. Techniques such as deep penetrating spatially offset Raman (SORS) have been combined with
nanoparticle based SERS in SESORS[72,73]. In brief, in the SORS technique, introduced in a paper by
Matousek et al, the Raman spectra are collected at positions spatially offset from the point of incidence
of the probe laser beam. Rather than using microscopic objectives for delivery and collection, fibre
probes are used. By moving the collection point away from the probe launch site, contributions from the
surface Raman photons are diminished and those of Raman photons from deeper within the sample are
increased. Using multivariate statistical methods, it is possible to reconstruct spectra from the different
layers with a much greater depth of penetration than a traditional confocal microscopy setup[74].

Depth sensitivities of up to several millimeters are now achievable and examples of emerging
applications include non-invasive diagnosis of bone disease, cancer and monitoring of glucose
levels[75] SESORS uses this same principal, taking advantage of the surface enhancement of the Raman
signal from metallic nanoparticles embedded within the sample. In a recent publication by Xie et al,
SESORS was used to identify bisphosphonate-functionalized nanotags on bone through 20mm of porcine
tissue[76]. This study highlights the increasing potential for in-vivo applications which SORS and SESORS
may have, in the field of nanomedicine.

SERS has enjoyed increasing popularity over the past decade, particularly since the emergence
of as increasing range of nanoprobes. However, the uptake rates and mechanisms as well as the
subsequent trafficking may be specific to the nanoparticle type, size and surface chemistry. Most SERS
probes are specifically designed for a target application and so are labels themselves for the SERS signal.
Furthermore, the molecular specificity of the surface enhancement process is not well understood.
Therefore, a truly label free method for generic monitoring and characterising the cellular uptake and
subcellular localisation of nanoparticles in general is still required.
TERS another method for generating enhancement of the Raman signal. Like nanoparticle based
SERS, this method is also based on probing of the inherent nanoscale environment of the sample in
close proximity to a nanoprobe and will therefore be discussed.

TERS
Tip Enhanced Raman spectroscopy, or TERS, is a method which combines Raman spectroscopy and
scanning probe microscopic techniques such as AFM. TERS, like SERS, is a method to enhance the
Raman signal and, in principle, the mechanism of enhancement is the same. Scanning probe tips have
dimensions of the order of tens of nanometers or less, and when metal coated, surface plasmon
resonances can be optically induced, similar to the case for metallic nanoparticles. In TERS, the
topography of the nanoscale environment of samples can be probed by bringing the tip into close
proximity with the area of the sample to be probed, but the Raman signal from the environment being
probed by the tip is selectively enhanced by several orders of magnitude, swamping the spontaneous
Raman from the remainder of the illuminated spot. Therefore TERS is a method which allows for very
small areas or even individual molecules to be probed in a label free manner.

TERS has been used to investigate viral cell interaction[77], cytochrome-c states in isolated
mitochondria[78], lipid and protein organisation in artificial cell membranes[79], as well as hemozoin
crystal formation inside malaria infected red blood cells, as shown in Figure 2 [80]. Figure 2 A –C show
AFM images of infected red blood cells, highlighting the hemozoin crystals inside the cellular vacuole in
C. Figure 2 D shows the TERS spectrum from the edge of the crystal deposits showing characteristic
peaks associated hemozoin and the profile is compared to the SERS and RRS spectra of β-hematin in F
and G . This study highlights TERS as a nanoscale technique with can be used to probe very specific areas
which may have implications in disease. In this instance, TERS provides a potential method to study the
interaction of quinoline anti-malarial drugs which are believed to preferentially bind to the edge of
hemozoin crystals.

Figure 2. TERS probing hemozoin crystal formation inside malaria infected red blood cells. A – C show
AFM images of infected red blood cells. D shows the TERS spectrum for the edge of the hemozoin crystal
deposit, E is the spectrum of the tip following retraction from the cell, F SERS spectrum of β-hematin, G
resonance Raman (RR) spectrum of β-hematin. Reproduced from [80].

TERS has also been used in the investigation of the interaction between cells and nanoparticles.
Alexander and Schultz (2012) were able to show the interaction of individual antibody conjugated
nanoparticles and cell surface bio molecules using TERS, with a similar sensitivity to SERS[81].
However, as TERS requires the use of AFM tips to enhance the signal, the method is restricted to
being a surface classification technique and thus is of limited use for intracellular or indeed ex-vivo or invivo tissue analysis. While surface enhanced methods provide promise in a number of nanomedical
areas, there are some caveats associated with these methods. Firstly, the probe must be capable of
generating a surface enhancement of the Raman signal; this is only applicable to certain types of gold
and silver particles or coated tips, as well as nanoaggregates of these metals. Additionally, these
techniques require a considerable expertise in synthetic chemistry and design of probes or tips for
specific target applications. Furthermore, reproducibility of the enhancement is also a concern, in
particular with TERS, were the reproducibility of the tip characteristics is important in gathering
reproducible spectra. Therefore it is important to consider that, while surface enhanced methods have
been shown to be capable of nanoscale accuracy, these methods are heavily reliant on specifically
designed nanoparticle sensors or probes and tips which in some way dilutes the label free aspect which
spontaneous Raman spectroscopy provides.
Spontaneous Raman Spectroscopy
To differentiate it from the numerous variants of Raman spectroscopy which have emerged over the
past decades, including SERS and TERS, the originally named phenomenon of Raman spectroscopy is
now frequently called spontaneous Raman spectroscopy. Spontaneous Raman spectroscopy has been
used extensively over the past decades for a range of biomedical applications and is emerging as a viable
alternative to gold standard protocols in medical diagnostics. Other uses include investigations in

blood[82] and serum samples[83], investigations of human skin[36,37], cellular investigations[84–86],
in-vivo[39] and ex-vivo[33] characterisations as well as studies of interaction of nanoparticles[34].
Importantly, these applications using Raman spectroscopy rely on the use of data analytical
methods which aid in the classification and understanding of the data which has been acquired. This
may entail the use of chemometric methods to cluster a data set so that one can see a cell or tissue as a
distribution of similar spectra in a map. Multivariate statistical methods can be employed for the
separation of two different classes of spectra e.g. a diseased and non-diseased state. A full description
of such analytical methods is beyond the scope of this review. However, it is important to highlight how
Raman spectroscopy and multivariate data mining approaches are commonly used together to
investigate the biochemical nature of samples. Some good examples of where these statistical methods
have been applied to Rama hyperspectral datasets can be found here[85,87,88].
Despite the extensive development of Raman spectroscopy for biomedical applications and the
specific use of SERS using nanoprobes, not many studies have explored the use of spontaneous Raman
spectroscopy for nanomedical applications. Of the reports that exist, some have aimed to look at
probing cells for a toxic response [34,89], others have aimed to look at how nanomaterials behave in a
cellular environment[32,90] and some have looked at degradation patterns of potential nanoparticle
drug carriers[91].
The potential of Raman spectroscopy as a toxicological screening method has been
demonstrated for the case of carbon nanotubes and their effects on human cells in vitro. Kneif et al
2010, showed how the cellular spectral signatures differed between control and exposed cells due to
changes in specific Raman spectral peaks of the cell nuclei. This method provided a way of investigating
the toxic response of cells to nanomaterials in a truly label free manner, compared to more typical dye
based cytotoxicity testing. In addition to detecting differences in response due to nanoparticle exposure,

it was also possible to statistically compare the dose dependent responses of the Raman signatures with
other gold standard toxicity tests, demonstrating the potential of the technique as a quantitative high
throughput screening assay[34].
In a different type of study by Dorney et al 2012, the aim was to demonstrate the potential of
Raman spectroscopy to visualise and investigate the interaction of polystyrene nanoparticles in cells.
The purpose was to use these particles, which are often used as a standard in toxicity studies, as a
model particle for further applications using Raman spectroscopy. In brief, the Raman spectroscopic
signatures of the cells were mapped with a step size of 0.75µm over a region which contained both
nuclear, perinuclear and cytoplasmic regions of the cell. Using a combination of K-means clustering and
principal component analysis, it was possible to identify the localisation of the particles inside cells
based on the intrinsic polystyrene signature and also to probe the chemical characteristics of the local
subcellular environment[32]. A highlight of the results in shown in Figure 3 for cells incubated for 24hrs
with polystyrene nanoparticles. The image in Figure 3 (i) shows the brightfield image (A) and the Kmeans image constructed for the Raman hyper spectral dataset (B). The polystyrene nanoparticles are
shown as green pixels in the image and the K-means average spectra are shown in Figure 3 (ii) A-D. The
cluster associated with the green pixels clearly shows characteristic peaks associated with polystyrene
when compared to a pure sample spectrum, Figure 3 (iii) A and B. The light blue and green clusters were
then compared using Principal Components Analysis showing that the nanoparticles are located in lipid
rich regions of the cell, which, by comparison with confocal fluorescence microscopy, was demonstrated
to be the endoplasmic reticulum.

Figure 3. Identification of intracellular distributions of polystyrene nanoparticles using Raman
spectroscopy. (i) A shows the brightfield and (B) K-means image of the cell. (ii) shows the K-means
K
cluster average spectraa associated with the clusters iin the K-means
means image in the panel above, (iii) shows
the K-means
means cluster spectrum associated with polystyrene nanoparticles (A) compared with a pure
spectrum of polystyrene (B).
B). The Right panel
panels show a Principal Component Analysis scatter plot (top),
differentiating the green (nanoparticle) and light blue clusters (cytoplasm)
(cytoplasm), and the loading of Principal
Component 1 (Bottom, A), suggesting the local environment surrounding th
the
e nanoparticles is lipid rich.
Reproduced from [32].
Additionally, in a follow up paper by Keating et al 2012, the supervised approach of spectral
cross correlation analysis (SCCA) for localisation of nanoparticles was used on the same spectral dataset.

It was thus possible to identify all the regions within the cell that contained polystyrene nanoparticles,
accounting for the misidentification of some clusters in the dataset that were apparent with K-means
cluster analysis. The localisation of the nanoparticles to a lipid rich region of the cell is highlighted in
Figure 4. Figure 4A and B show a pure polystyrene and lipid spectrum which have been cross correlated
against the dataset to produce the pseudo colour images in Figure 4C, showing the lipid distribution,
Figure 4D the distribution of polystyrene and the merge of the two in Figure 4E. This method provides a
clear analytical approach for identification of nanomaterials and separation of different regions of the
cell with a particular biochemical distribution[92].

Figure 4. Verification of identification of intracellular nanoparticles using spectral cross correlation
analysis (SCCA). (A) and (B) show a pure spectrum of polystyrene nanoparticles and 3-sn3
phosphatidylethanolamine. (C) and (D) show the pseudo colour image of lipid and nanoparticle
distribution following SCCA with 3--sn- phosphatidylethanolamine and polystyrene. The merged image is
shown in E, indicating the particles in a lipid rich environment. Adapted from [92].

Another recent study by Chernenko et al[93] aimed to investigate how different types of
deuterated liposomal nanoparticles are distributed in cells. More specifically, it aimed to investigate
how different chemical compositions affected how the liposomes associated with the mitochondrion.
Notable in this study is the use of deuterated liposomes to enhance the ability to differentiate liposomes
from endogenous lipids in the cell, based on the fact that the C-D vibrational frequency is significantly
down shifted from that of the C-H stretch of the very abundant intrinsic macromolecules of the cell.
Another paper by the same group also looked at the degradation of polymeric nanoparticles over time
in cells and concluded that poly lactic-co-glycolic acid (PLGA) and polycaprolactone (PCL) drug delivery
systems are degraded and incorporated into the late endosomes of the Golgi system, based on spectral
changes associated with the specific degradation patterns of the nanocarriers[91].
Spontaneous Raman spectroscopy has therefore already been demonstrated to be a chemically
specific method for investigating nanoparticle interactions and also to probe the biochemical nature of
cells. Notably, a number of biochemical features can be accessed simultaneously without the need for
fluorescence or other labelling methods, or for costly cytotoxicological assays. It should be noted,
however, that, based on current technologies, spontaneous Raman is a relatively weak effect, thus
highlighting the attention which surface enhanced techniques such as SERS and TERS have received.
Relatively weak signals can be compensated for by longer acquisition times, with maximum 2D scan
times of the order of 40-80 mins for a 50µm*50µm area with a step size of 500nm for cellular data[94].
However, these scan speeds are largely dependent on the required signal to noise ratio and the step size
used in image acquisition. For these reasons real-time imaging has not been realised to date.
Ultimately, for in vivo applications, penetration depth is also an important consideration. In
Raman microscopy, sensitivities are optimised by choice of objective, providing optical spatial resolution
but limited penetration depth (~1-50µm). As Raman spectroscopy is an optical technique, the

penetration depth is largely determined by the choice of wavelength of the source laser, and optimally
this can be chosen in the near infrared region where tissue has a transmission window. Absorption is
largely governed by that of chromophores such as melanin (in skin) or haemoglobin across the visible,
and by the overtones of OH vibrations in the near infra red regions. Scattering is an additional loss
mechanism, but the development of Spatially Off-Set Raman Spectroscopy [75] using fibre probe rather
than microscope objective delivery and collection optics, has exploited the fact that the signal from the
deeper layers is scattered to a greater extent, to improve penetration depth sensitivities. CARS is
another label free type of Raman scattering which can be used to probe bio and nanomedical scenarios
and in recent years has seen a growth in applications in cells, tissues and in-vivo imaging. Using single
wavelengths, imaging of large areas can be achieved at video rates.

CARS
Coherent anti-Stokes Raman spectroscopy (CARS) is a form of Raman spectroscopy whereby the antiStokes shifted Raman signal is used to probe the molecular bonds within a sample. The coherent process
takes advantage of a third order non-linear optical phenomenon by which three beams are used to
probe the sample. A fixed pump laser beam, a tunable probe beam are set at a frequency difference
which is exactly equal to the frequency of a specific molecular vibration, resulting in the coherent build
up of a scattered signal on the anti-Stokes side of the pump laser frequency [95,96]. The signal can be
orders of magnitude larger than a spontaneous Raman signal. Thus, CARS can be used to rapidly
generate images of a particular biochemical distribution and therefore can be used in the generation of
video rate image sequences of cells and tissues. To generate a full spectroscopic signature, however, the
pump beam has to be tuned such that the difference frequencies scan the vibrational spectrum, a
process which can take considerable time, under current technological constraints. The nonlinear

process is furthermore intensity dependent, requiring costly and notoriously temperamental short pulse
lasers, whereas spontaneous Raman can be conducted with conventional steady state lasers.
In a biomedical context, the technique has been used to investigate a number of phenomena,
also in conjunction with other methods such as immuno fluorescent labelling. Primarily, CARS has been
used in the study of the C-H stretch region which is most commonly associated with lipids in living
organisms. Examples include the use of CARS for the study of atherosclerotic lesions[97], intracellular
trafficking[98], drug delivery[99], cancer metastasis[100], quantitative imaging of lipid distributions in
living Caenorhabditis elegans[101] as well as imaging of the axonal myelin both in-vivo and exvivo[102,103] CARS has also been used in the assessment of nanomaterials. Notably ,the technique
has been used to study particle interaction in biological organisms, receptor mediated particle
uptake[104] as well as the effects of particle size and coating on zebra fish embryos[105]. Moger et
al[106] used CARS to investigate the interaction of metal oxide nanoparticles within the gills of rainbow
trout, Onchrhynchus mykiss. They were able to show in a label free manner the translocation of TIO2
particles across the epithelial membrane and into the capillaries in fish gill tissue. This is shown in figure
5, which illustrates the forward (a) and epi-CARS images (b) of exposed fish gills. The merged image
shows the localisation of the particles in the gill tissues, revealing particle clumps in green.

Figure 5. CARS images of the TiO2 nanoparticle distribution in Onchrhynchus mykiss gills, (a) forward
CARS image showing the nanoparticles, (b) epi-CARS image of the gill tissue and (c) merged forward and
epi CARS image. Images reproduced from [106].

The method has also recently been used to investigate the mechanisms of oral uptake of
Quaternary Ammonium Palmitoyl Glycol chitosan (GCPQ) nanoparticles. In this study, the particles were
deuterated to shift the CH2 stretching vibration located at 2840cm-1 to a CD2 stretching vibration of
2100cm-1. This allows for CARS to be carried out in the so called ‘silent region’ of the cell. Additionally
second harmonic generation and two photon fluorescence were used to image the tissue containing
nanoparticles. In doing this, Garrett et al. were able to examine chitosan uptake and recirculation in the
gut by being able to target the nanoparticles with cellular precision to the gastrointestinal tract, liver
and gall bladder, providing novel insights in the role of enterocytes and bile recirculation regarding
chitosan nanoparticles [99,107]. Figure 6 shows the identification of the deuterated nanoparticles in
green (2100cm-1), which are highlighted by the arrows. Figure 6A and 6B show liver and stomach tissue
respectively, with the C-D2 resonance being used to identify the deuterated nanoparticles (2100cm-1) in
green and the C-H2 (2845cm-1) in red. Figure 6C shows a multimodal label free imaging approach
combining CARS imaging (green), second harmonic generation (SHG) and two photon fluorescence (TPF)
in imaging nanoparticle interaction with jejunum tissue. Figure 6D and 6E show the use of a combination
of CARS and TPF to image the ileum and duodenum respectively, while Figure 6F shows a combination
of CARS, SHG and TPF of the gall bladder. These approaches show not only how CARS can be used to
probe nanoparticle interactions, but also highlight how multiple imaging approaches can be combined in
multimodal approaches to give different types of information building towards a more complete picture.

Figure 6: Epi-CARS images with contrast derived from CD2 and CH2 resonances in GCPQ nanoparticles at
2100 cm−1 (green) and 2845cm−1 (red) respectively. (A) Liver tissue. (B) Stomach tissue samples. (C)
shows Jejunum tissue imaged with epi-CARS with contrast derived from the CD2 resonance (green), SHG
contrast derived from collagen (blue) and TPF contrast derived from endogenous fluorophores. (D)
Ileum tissue imaged with epi-CARS with contrast derived from the CD2 and TPF (red) (E) Duodenum
imaged with epi-CARS with contrast derived from the CD2 and TPF (red). (F) Gall bladder imaged with
epi-CARS with contrast derived from the CD2 resonance (green), SHG (blue) and TPF (red). Reproduced
from [99]

Surface enhancement can also be exploited in the CARS format. Surface enhanced CARS
(SECARS) has been used in conjunction with nanoparticles and has been shown to be capable of
achieving greater signal enhancement than that of SERS or CARS alone. For biomedical applications, it
has also been used for the detection of single molecules of deoxyadenosine and deoxyguanosine

monophosphate (dAMP and dGMP) [108] and has also been used in immuno-histochemistry
studies[109].

Conclusions and Outlook
This article has attempted to provide an overview of the current state of the art of the developing
applications of Raman spectroscopic techniques in Nanomedicine. A recent review has dealt more
broadly with the applications of these techniques in the investigation of the interaction of nanomaterials
with complex biological systems [110]. The development of biomedical applications of vibrational
spectroscopy, both Raman and IR, has been extremely active for the past two decades and more and the
challenges to nanomedical applications are intrinsically linked, as indeed they are to those of the
fundamental understanding of nanobio interactions in general.
As a molecular specific tool, Raman spectroscopy can potentially aid significantly to the understanding
of nanobio interactions in vitro. Even before interaction with the cell, it has been argued that the
biological identity of the nanoparticle is determined by the surface coatings of the dispersion medium,
the co-called protein corona [111]. While SERS active nanoparticles can be employed to probe this
interaction acellularly, there is evidence that the nanoparticle medium interaction is very specific to the
surface characteristics and size, and thus the use of truly label free spontaneous Raman spectroscopy
may lead to broader insights. In this context, the increased sensitivity of TERS may be of significant
benefit. SERS has however demonstrated that the surface coating can evolve significantly after
endocytosis of the nanoparticle [110], and this is a critical consideration in the bioavailability of surface
functionalities, including release of active ingredients, which have been specifically designed for
nanomedical applications.

As an confocal optical microscopic technique, Raman holds all the benefits of confocal
fluorescence techniques, but has the potential advantage of being truly label free, adding the promise of
reduced cost and sample processing requirements. SERS probes have demonstrated the potential to
probe nanoparticle uptake, trafficking as well as the local environment, but these probes need to be
specifically chemically tailored for the given application can so the technique cannot be considered to be
truly label free. Spontaneous Raman spectroscopy is, on the other hand, an intrinsically weak
phenomenon and cellular mapping is often a prolonged processes. Nevertheless, a number of cellular
studies have been conducted which, although not specifically probing nanoparticles, may have
implications in future nanomedical applications. For example, some studies have shown the application
of Raman to drug delivery investigations [112,113] while other studies have identified sub cellular
structures such as the mitochondrion as well as lipid rich regions which may be associated with the Golgi
and endoplasmic reticulum [86]. Klein et al. used image registration and immuno fluorescence to verify
the locations of cellular organelles and also as a means of extracting the spectra which were specifically
associated with the organelle[114]. These studies could be extended to look at nanoparticle trafficking
studies, colocalizing the particle to an organelle in a label free manner, without using fluorescently
labelled nanoparticles or organelle stains. Although spontaneous Raman studies are commonly
conducted on fixed cells, live cell spectral profiling has been demonstrated [37]. Image analysis is
ultimately dependent on the reliability of multivariate chemometric techniques and simulated model
systems can prove invaluable in validating their accuracy [81]. Increased acquisition rates can be
achieved by systems custom designed for biological applications, and CARS potentially offers a route
towards routine in vitro screening of intracellular nanobio interactions, although its ability to rapidly
screen the full spectrum is currently limited by the (tuneable) laser source technologies and applications
are thus restricted by the need to identify specific spectral marker bands.

In terms of disease diagnostics, ex vivo applications of Raman spectroscopy have received much
attention. For the range of Raman modalities, however, mapping of large areas of tissue biopsies also
suffer from issues of weak signals (spontaneous), specifically targeted probes (SERS), surface sensitivity
(TERS) or the need for specific spectral markers (CARS). As a chemically specific probe, however, Raman
techniques are particularly suitable for analysis of biomarkers of disease in biological fluids [71,72] and
this suitability is readily extended to applications in nanomedicine.
Raman scattering is fundamentally an optical technique and in vivo applications are thus limited by the
ability to access the area of interest. For dermal analysis, custom designed systems are commercially
available which exploit the near infrared transmission window of skin, although, in a microscopic format,
the penetration depth is further limited by the delivery optics, typically to some hundreds of microns.
Advances in SORS have increased the depth resolution, and such technologies could prove invaluable
tools for analysis of transdermal nanodrug delivery or environmental exposure to nanoparticles. As an
optical technique, Raman spectroscopy readily lends itself to endoscopic probes [115], however, and
recent advances in such in vivo probes may significantly impact on biomedical applications of Raman
spectroscopy, including, inevitably Nanomedicine.
Future Perspectives
The field of nanotechnology is set to grow ever rapidly as new applications and avenues of research are
explored over the coming decade. Crucially, characterisation and visualisation methods in a medical
setting must develop in tandem, to access the applicability of such nanotechnology. Raman
spectroscopy represents a method proven in the field of disease diagnostics and biomedical imaging and
thus by extension holds the capability to progress the field of nanomedicine.
Spontaneous Raman spectroscopy provides a versatile and truly label free method which has seen
success in a number of different medical applications, most notably in disease diagnostics. Key enabling

technological developments in this context include endoscopic and other in vivo probes. Relatively Low
signal strengths currently limit the technique to small areas and/or long scan times, however, and
continuing improvements in signal throughput and detector sensitivities are important. EU Directives
limiting the use of animal models will put increasing emphasis on the development of in vitro screening
methods and Raman is a potential candidate for high content analysis of, for example, the efficacy and
mode of action of novel chemotherapeutical agents of toxicants. The high optical resolutions obtainable
make Raman particularly suitable for acellular or subcellular studies of nanobio interactions. As the
sensitivity of the Raman technique is intimately linked with the multivariate statistical data analysis
methods, the quantitative specificities of these methods must be established. This can only be done if
the true result is known, and in this context the use of specifically constructed model datasets may
provide a quantifiable insight into how far Raman spectroscopy can be pushed in both a medical and
nanomedical context.
SERS provides increased sentitivities to probe the nanoscale environment surrounding metallic
nanoparticles. Although the technique is not truly label free, with the increased sensitivities achievable
as well as the targeting potential of such probes, SERS may provide alternative imaging strategies for
disease diagnostics in-vivo, as well as provide enhanced methods for the monitoring of human fluids
such as serum and other metabolic excretions ex-vivo. SERS in-vitro may also prove a useful tool in
probing the nature of the so called protein corona of nanoparticles in biological media and thus provide
valuable insights into the surface behaviour of nanomaterials in a biological setting. Other enhancement
methods such as TERS also provide novel insights into the nanoscale environment although they are
limited by being mainly a molecular or surface specific technique.
Coupling these advances in spontaneous and surface enhanced Raman with the development of SORS
and SESORS, some of the shortcomings in signal generation and depth penetration of Raman

spectroscopy in-vivo may be overcome. In addition to the development of endoscopic and needle based
probes which will increase access to the point of interest, realistic applicable in-vivo Raman studies in
nanomedicine may not be too far away. CARS provides a method which is capable of video rate scan
speeds. However, as of yet the technique is not a spectroscopic imaging technique as it only allows for
the probing of one particular wave number or vibrational marker at a time. The technique therefore
requires a clearly identifiable biomarker for imaging, which may not be the case for all biomolecules. A
CARS system that could provide a spectrum of the finger print region of the sample with similar real
time imaging capabilities would be ideal. Specifically for CARS to progress as a spectroscopic imaging
modality, advances in laser technology such as rapidly tunable lasers will need to develop in tandem.
These advances would then open a myriad of applications for CARS imaging along the lines of
spontaneous Raman imaging.

Executive Summary
Raman Spectroscopy: Raman spectroscopy is a well established chemical analysis technique finding
increasingly broader applications, particularly in biochemical analysis and disease diagnostics.
Surface/Tip enhanced Raman Spectroscopy: The techniques of SERS and TERS specifically probe the
nanoscale and, although TERS is a topical/surface technique, SERS probes have already been used
extensively for in vitro and in vivo studies. SERS probes are normally chemically functionalised according
to the specific target, and so the technique is arguably not truly label free.
Spontaneous Raman Spectroscopy: As a truly label free technique, (spontaneous) Raman spectroscopy,
coupled with multivariate analytical techniques potentially provides a probe of nanoparticles in

cells/tissue, their nature of their local environment, and physiological changes. Unenhanced, the signals
are however relatively weak, and large scale mapping can be time consuming.
Coherent anti-Stokes Raman Spectroscopy: CARS is a nonlinear optical technique which is increasing in
prominence for biomedical applications. Tuned to a specific vibrational frequency, it can scan large areas
(cm2) at video rates. Currently, however, it is not a spectroscopic technique and does not avail of the full
biochemical information available, but relies on the presence of a specific spectral marker.
Outlook: The range of modalities of Raman spectroscopy potentially hold great promise for biomedical
and nanomedical applications, although many technical challenges remain.

References
1.

Freitas R. Nanomedicine, volume I: basic capabilities . Landes Bioscience, Georgetown, TX,

2.

Kumar A, Vemula PK, Ajayan PM, John G. Silver-nanoparticle-embedded antimicrobial paints
based on vegetable oil. Nature materials. 7(3), 236–41 (2008).

3.

Perelshtein I, Applerot G, Perkas N, Grinblat J, Gedanken A. A one-step process for the
antimicrobial finishing of textiles with crystalline TiO2 nanoparticles. Chemistry (Weinheim an der
Bergstrasse, Germany). 18(15), 4575–82 (2012).

4.

Yan H, Choe HS, Nam S, et al. Programmable nanowire circuits for nanoprocessors. Nature .
470(7333), 240–4 (2011).

5.

Nakano K, Egashira K, Masuda S, et al. Formulation of nanoparticle-eluting stents by a cationic
electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric
nanoparticle-eluting stents in porcine coronary arteries. JACC. Cardiovascular interventions . 2(4),
277–83 (2009).

6.

Will O, Purkayastha S, Chan C, et al. Diagnostic precision of nanoparticle-enhanced MRI for
lymph-node metastases: a meta-analysis. The lancet oncology . 7(1), 52–60 (2006).

7.

Skotland T, Iversen T-G, Sandvig K. New metal-based nanoparticles for intravenous use:
requirements for clinical success with focus on medical imaging. Nanomedicine: nanotechnology,
biology, and medicine . 6(6), 730–7 (2010).

8.

Korin N, Kanapathipillai M, Matthews BD, et al. Shear-activated nanotherapeutics for drug
targeting to obstructed blood vessels. Science (New York, N.Y.) . 337(6095), 738–42 (2012).

9.

Gaspar VM, Correia IJ, Sousa A, et al. Nanoparticle mediated delivery of pure P53 supercoiled
plasmid DNA for gene therapy. Journal of controlled release: official journal of the Controlled
Release Society . 156(2), 212–22 (2011).

10.

Jin H, Lovell JF, Chen J, et al. Mechanistic insights into LDL nanoparticle-mediated siRNA delivery.
Bioconjugate chemistry . 23(1), 33–41 (2012).

11.

Bouwmeester H, Lynch I, Marvin HJP, et al. Minimal analytical characterization of engineered
nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology . 5(1), 1–11
(2011).

12.

Nair BG, Fukuda T, Mizuki T, Hanajiri T, Maekawa T. Intracellular trafficking of superparamagnetic
iron oxide nanoparticles conjugated with TAT peptide: 3-dimensional electron tomography
analysis. Biochemical and biophysical research communications . 421(4), 763–7 (2012).

13.

Mu Q, Hondow NS, Krzemiński L, Brown AP, Jeuken LJ, Routledge MN. Mechanism of cellular
uptake of genotoxic silica nanoparticles. Particle and fibre toxicology . 9, 29 (2012).

14.

Willig KI, Rizzoli SO, Westphal V, Jahn R, Hell SW. STED microscopy reveals that synaptotagmin
remains clustered after synaptic vesicle exocytosis. Nature . 440(7086), 935–9 (2006).

15.

Rust MJ, Bates M, Zhuang X. imaging by stochastic optical reconstruction microscopy ( STORM ).
Nature methods. 3(10), 793–795 (2006).

16.

Zhuang X. Nano-imaging with Storm. Nature photonics . 3(7), 365–367 (2009).

17.

Sandin P, Fitzpatrick LW, Simpson JC, Dawson K a. High-speed imaging of Rab family small
GTPases reveals rare events in nanoparticle trafficking in living cells. ACS nano . 6(2), 1513–21
(2012).

18.

Fazlollahi F, Angelow S, Yacobi NR, et al. Polystyrene nanoparticle trafficking across MDCK-II.
Nanomedicine: nanotechnology, biology, and medicine . 7(5), 588–94 (2011).

19.

Jan E, Byrne SJ, Cuddihy M, et al. High-content screening as a universal tool for fingerprinting of
cytotoxicity of nanoparticles. ACS nano . 2(5), 928–38 (2008).

20.

Contreras J, Xie J, Chen YJ, et al. Intracellular uptake and trafficking of difluoroboron
dibenzoylmethane-polylactide nanoparticles in HeLa cells. ACS nano . 4(5), 2735–2747 (2010).

21.

Pawley J. Handbook of biological confocal microscopy. 3rd ed. Springer-Verlag, Heidelberg.

22.

Aparicio-Ixta L, Ramos-Ortiz G, Pichardo-Molina JL, et al. Two-photon excited fluorescence of
silica nanoparticles loaded with a fluorene-based monomer and its cross-conjugated polymer:
their application to cell imaging. Nanoscale . 4(24), 7751–9 (2012).

23.

Yang Y, An F, Liu Z, et al. Ultrabright and ultrastable near-infrared dye nanoparticles for in vitro
and in vivo bioimaging. Biomaterials . 33(31), 7803–9 (2012).

24.

Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere N a. Surface coatings determine cytotoxicity
and irritation potential of quantum dot nanoparticles in epidermal keratinocytes. The Journal of
investigative dermatology . 127(1), 143–53 (2007).

25.

Bharali DJ, Klejbor I, Stachowiak EK, et al. Organically modified silica nanoparticles: a nonviral
vector for in vivo gene delivery and expression in the brain. Proceedings of the National Academy
of Sciences of the United States of America . 102(32), 11539–44 (2005).

26.

Cang H, Xu CS, Montiel D, Yang H. Guiding a confocal microscope by single fluorescent
nanoparticles. Optics letters . 32(18), 2729–31 (2007).

27.

Gajraj A, Ofoli R. Effect of extrinsic fluorescent labels on diffusion and adsorption kinetics of
proteins at the liquid-liquid interface. Langmuir . (22), 8085–8094 (2000).

28.

Win KY, Feng S-S. In vitro and in vivo studies on vitamin E TPGS-emulsified poly(D,L-lactic-coglycolic acid) nanoparticles for paclitaxel formulation. Biomaterials . 27(10), 2285–91 (2006).

29.

Suh H, Jeong B, Liu F KS. Cellular uptake study of biodegradable nanoparticles in vascular smooth
muscle cells. Pharm Res. ;15(9), 1495–8 (1998).

30.

Salvati A, Aberg C, Dos Santos T, et al. Experimental and theoretical comparison of intracellular
import of polymeric nanoparticles and small molecules: toward models of uptake kinetics.
Nanomedicine: nanotechnology, biology, and medicine . 7(6), 818–26 (2011).

31.

Wang G, Stender AS, Sun W, Fang N. Optical imaging of non-fluorescent nanoparticle probes in
live cells. Analyst . 135(2), 215–21 (2010).

32.

Dorney J, Bonnier F, Garcia A, Casey A, Chambers G, Byrne HJ. Identifying and localizing
intracellular nanoparticles using Raman spectroscopy. Analyst . 137(5), 1111–9 (2012).

(**) Raman spetroscopy is demonstrated as a viable label free in-vitro imaging technique in the
investigation of nanoparticle cell interaction.
33.

Lyng FM, Faoláin EO, Conroy J, et al. Vibrational spectroscopy for cervical cancer pathology, from
biochemical analysis to diagnostic tool. Experimental and molecular pathology . 82(2), 121–9
(2007).

34.

Knief P, Clarke C, Herzog E, et al. Raman spectroscopy--a potential platform for the rapid
measurement of carbon nanotube-induced cytotoxicity. Analyst . 134(6), 1182–91 (2009).

35.

Lattermann A, Matthäus C, Bergner N, et al. Characterization of atherosclerotic plaque
depositions by Raman and FTIR imaging. Journal of biophotonics . 6(1), 110–21 (2013).

36.

Tfaili S, Gobinet C, Josse G, Angiboust J-F, Manfait M, Piot O. Confocal Raman microspectroscopy
for skin characterization: a comparative study between human skin and pig skin. Analyst .
137(16), 3673–82 (2012).

37.

Ali SM, Bonnier F, Tfayli A. Raman spectroscopic analysis of human skin tissue sections ex-vivo:
evaluation of the effects of tissue processing and dewaxing. Journal of Biomedical Optics . 18(6),
doi:10.1117/1.JBO.18.6.061202 (2013).

38.

Bonnier F, Meade a D, Merzha S, et al. Three dimensional collagen gels as a cell culture matrix for
the study of live cells by Raman spectroscopy. Analyst . 135(7), 1697–703 (2010).

39.

Lui H, Zhao J, McLean D, Zeng H. Real-time Raman spectroscopy for in vivo skin cancer diagnosis.
Cancer research . 72(10), 2491–500 (2012).

40.

Colthup N, Daly L, Wiberley S. Introduction to infrared and Raman spectroscopy . Academic Press,
New York

41.

Smith E, Dent G. Modern Raman spectroscopy: a practical approach . John Wiley and Sons, New
York

42.

D.A. Long. The Raman Effect: A Unified Treatment of the Theory of Raman Scattering by
Molecules. John Wiley and Sons, New York.

43.

Lewis I, Edwards H. Handbook of Raman spectroscopy: from the research laboratory to the
process line . CRC Press

44.

Parker F. Applications of infrared, Raman, and resonance Raman spectroscopy in biochemistry .
Springer-Verlag, Heidelberg

45.

Lyon LA, Keating CD, Fox AP, et al. Raman Spectroscopy. Analytical Chemistry . 70(12), 341–362
(1998).

46.

Tolles WM, Mcdonald JR, Harvey AB. feature article A Review of the Theory and Application of
Coherent Anti-Stokes Raman Spectroscopy ( CARS ). 31(4) (1977).

47.

Stiles PL, Dieringer J a, Shah NC, Duyne RP. Surface-enhanced Raman spectroscopy. Annual
review of analytical chemistry (Palo Alto, Calif.). 1, 601–26 (2008).

48.

Byrne H, Sockalingum G, Stone N. Raman Microscopy: Complement or Competitor . In:
Biomedical Applications of Synchrotron Infrared Microspectroscopy. Springer, 105–142 (2011).

49.

Fleischmann M, Hendra P, McQuillan A. Raman spectra of pyridine adsorbed at a silver electrode.
Chemical Physics Letters . 26(2), 163–166 (1974).

50.

Jeanmaire D, Duyne R Van. Surface Raman spectroelectrochemistry: Part I. Heterocyclic,
aromatic, and aliphatic amines adsorbed on the anodized silver electrode. Journal of
Electroanalytical Chemistry and … . 84, 1–20 (1977).

51.

Blackie E, Ru E Le, Etchegoin P. Single-molecule surface-enhanced Raman spectroscopy of
nonresonant molecules. Journal of the American Chemical Society 131(40), 14466–72 (2009).

52.

Stiles PL, Dieringer J a, Shah NC, Van Duyne RP. Surface-enhanced Raman spectroscopy. Annual
review of analytical chemistry (Palo Alto, Calif.) . 1, 601–26 (2008).

53.

Michael Y, Xu H, Penn S, Cromer R. SERS nanoparticles: a new optical detection modality for
cancer diagnosis. Nanomedicine . 2, 725–734 (2007).

54.

Chourpa I, Lei F, Dubois P. Intracellular applications of analytical SERS spectroscopy and
multispectral imaging. Chemical Society Reviews. 37, 993–1000 (2008).

55.

Xie W, Qiu P, Mao C. Bio-imaging, detection and analysis by using nanostructures as SERS
substrates. Journal of materials chemistry . 21, 5190–5202 (2011).

56.

Chen Y, Zheng X, Chen G, et al. Immunoassay for LMP1 in nasopharyngeal tissue based on
surface-enhanced Raman scattering. International journal of nanomedicine . 7, 73–82 (2012).

57.

Schütz M, Steinigeweg D, Salehi M, Kömpe K, Schlücker S. Hydrophilically stabilized gold
nanostars as SERS labels for tissue imaging of the tumor suppressor p63 by immuno-SERS
microscopy. Chemical communications (Cambridge, England) . 47(14), 4216–8 (2011).

58.

Qian X, Peng X-H, Ansari DO, et al. In vivo tumor targeting and spectroscopic detection with
surface-enhanced Raman nanoparticle tags. Nature biotechnology . 26(1), 83–90 (2008).

59.

Jokerst J V, Cole AJ, Van de Sompel D, Gambhir SS. Gold nanorods for ovarian cancer detection
with photoacoustic imaging and resection guidance via Raman imaging in living mice. ACS nano .
6(11), 10366–77 (2012).

60.

Stevenson R, Ingram A, Leung H, McMillan DC, Graham D. Quantitative SERRS immunoassay for
the detection of human PSA. Analyst . 134(5), 842–4 (2009).

61.

Isola NR, Stokes DL, Vo-Dinh T. Surface-enhanced Raman gene probe for HIV detection. Analytical
chemistry . 70(7), 1352–6 (1998).

62.

Monaghan PB, Mccarney KM, Ricketts A, et al. Bead-Based DNA Diagnostic Assay for Chlamydia
Resonance Raman Scattering Detection within a Lab-on-a-Chip Format. Analytical chemistry.
79(7), 2844–2849 (2007).

63.

Kneipp J, Kneipp H, Rajadurai A, Redmond RW, Kneipp K. Optical probing and imaging of live cells
using SERS labels. Journal of Raman Spectroscopy . 40(1), 1–5 (2009).

64.

Kneipp J, Kneipp H, Rice WL, Kneipp K. Optical probes for biological applications based on
surface-enhanced Raman scattering from indocyanine green on gold nanoparticles. Analytical
chemistry . 77(8), 2381–5 (2005).

65.

Kneipp J, Kneipp H, McLaughlin M, Brown D, Kneipp K. In vivo molecular probing of cellular
compartments with gold nanoparticles and nanoaggregates. Nano letters. 6(10), 2225–31 (2006).

66.

Kneipp J, Kneipp H, McLaughlin M, Brown D, Kneipp K. In vivo molecular probing of cellular
compartments with gold nanoparticles and nanoaggregates. Nano letters . 6(10), 2225–31
(2006).

67.

Kneipp J, Kneipp H, Wittig B, Kneipp K. Following the Dynamics of pH in Endosomes of Live Cells
with SERS Nanosensors . The Journal of Physical Chemistry C . 114(16), 7421–7426 (2010).

68.

Kong KV, Lam Z, Goh WD, Leong WK, Olivo M. Metal carbonyl-gold nanoparticle conjugates for
live-cell SERS imaging. Angewandte Chemie (International ed. in English) . 51(39), 9796–9 (2012).

69.

Lin J, Chen R, Feng S, et al. A novel blood plasma analysis technique combining membrane
electrophoresis with silver nanoparticle-based SERS spectroscopy for potential applications in
noninvasive cancer detection. Nanomedicine: nanotechnology, biology, and medicine . 7(5), 655–
63 (2011).

70.

McQueenie R, Stevenson R, Benson R, et al. Detection of inflammation in vivo by surfaceenhanced Raman scattering provides higher sensitivity than conventional fluorescence imaging.
Analytical chemistry . 84(14), 5968–75 (2012).

71.

Kneipp K, Kneipp H. Single molecule Raman scattering. applied spectroscopy . 60, 322–334
(2006).

72.

Ma K, Yuen J, Shah N. In-vivo, transcutaneous glucose sensing using surface-enhanced spatially
offset Raman spectroscopy: multiple rats, improved hypoglycemic accuracy, low incident
power,and continious monitoring for 17 days. Analytical Chemistry 83, 9146–9152 (2011).

73.

Stone N, Faulds K, Graham D, Matousek P. Prospects of Deep Raman Spectroscopy for
Noninvasive Detection of Conjugated Surface Enhanced Resonance Raman Scattering
Nanoparticles Buried within 25 mm of Mammalian Tissue. Analytical chemistry. 82(10), 3969–
3973 (2010).

74.

P. Matousek, I. P. Clark, E. R. C. Draper, M. D. Morris, A. E. Goodship, N. Everall, M. Towrie, W. F.
Finney and AWP. Subsurface probing in diffusely scattering media using spatially offset Raman
spectroscopy. Applied Spectroscopy . 59(4), 393–400 (2005).

75.

Matousek P, Stone N. Recent advances in the development of Raman spectroscopy for deep noninvasive medical diagnosis. Journal of biophotonics . 6(1), 7–19 (2013).

76.

Xie H, Stevenson R, Stone N, Hernandez-Santana A, Faulds K, Graham D. Tracking
bisphosphonates through a 20 mm thick porcine tissue by using surface-enhanced spatially offset
Raman spectroscopy. Angewandte Chemie (International ed. in English) . 51(34), 8509–11 (2012).

(**) SESORS is demonstrated as an ex-vivo method for nanoparticle identification, highlighting the
increasing movement of Raman based techniques into a more in-vivo setting.

77.

Hermann P, Hermelink A, Lausch V, et al. Evaluation of tip-enhanced Raman spectroscopy for
characterizing different virus strains. Analyst . 136(6), 1148–52 (2011).

78.

Böhme R, Mkandawire M, Krause-Buchholz U, et al. Characterizing cytochrome c states--TERS
studies of whole mitochondria. Chemical communications (Cambridge, England) . 47(41), 11453–
5 (2011).

79.

Deckert-Gaudig T, Deckert V. Nanoscale structural analysis using tip-enhanced Raman
spectroscopy. Current opinion in chemical biology . 15(5), 719–24 (2011).

80.

Wood B, Bailo E, Khiavi M, Tilley L. Tip-enhanced Raman scattering (TERS) from hemozoin crystals
within a sectioned erythrocyte. Nano letters . 11, 1868–1873 (2011).

(*) Demonstrates the power of TERS in the label free investigation of nanoscale drug interaction.
81.

Alexander KD, Schultz ZD. Tip-enhanced Raman detection of antibody conjugated nanoparticles
on cellular membranes. Analytical chemistry . 84(17), 7408–14 (2012).

82.

Shao J, Lin M, Li Y, et al. In vivo blood glucose quantification using Raman spectroscopy. PloS one
. 7(10), e48127 (2012).

83.

Poon KWC, Lyng FM, Knief P, et al. Quantitative reagent-free detection of fibrinogen levels in
human blood plasma using Raman spectroscopy. Analyst . 137(8), 1807–14 (2012).

84.

Bonnier F, Knief P, Lim B, et al. Imaging live cells grown on a three dimensional collagen matrix
using Raman microspectroscopy. Analyst . 135(12), 3169–77 (2010).

85.

Miljković M, Chernenko T, Romeo MJ, Bird B, Matthäus C, Diem M. Label-free imaging of human
cells: algorithms for image reconstruction of Raman hyperspectral datasets. Analyst . 135(8),
2002–13 (2010).

86.

Matthäus C, Chernenko T, Newmark J a, Warner CM, Diem M. Label-free detection of
mitochondrial distribution in cells by nonresonant Raman microspectroscopy. Biophysical journal
. 93(2), 668–73 (2007).

87.

Bonnier F, Byrne HJ. Understanding the molecular information contained in principal component
analysis of vibrational spectra of biological systems. Analyst . 137(2), 322–32 (2012).

88.

Hedegaard M, Matthäus C, Hassing S, Krafft C, Diem M, Popp J. Spectral unmixing and clustering
algorithms for assessment of single cells by Raman microscopic imaging. Theoretical Chemistry
Accounts . 130(4-6), 1249–1260 (2011).

89.

Candeloro P, Tirinato L, Malara N, et al. Nanoparticle microinjection and Raman spectroscopy as
tools for nanotoxicology studies. Analyst . 136(21), 4402–8 (2011).

90.

Van Manen H-J, Kraan YM, Roos D, Otto C. Single-cell Raman and fluorescence microscopy reveal
the association of lipid bodies with phagosomes in leukocytes. Proceedings of the National
Academy of Sciences of the United States of America . 102(29), 10159–64 (2005).

91.

Chernenko T, Matthäus C, Milane L, Quintero L, Amiji M, Diem M. Label-free Raman spectral
imaging of intracellular delivery and degradation of polymeric nanoparticle systems. ACS nano .
3(11), 3552–9 (2009).

(*) Demonstration of the In-vitro imaging chemical imaging capabilities of Raman spectroscopy.
92.

Keating ME, Bonnier F, Byrne HJ. Spectral cross-correlation as a supervised approach for the
analysis of complex Raman datasets: the case of nanoparticles in biological cells. Analyst .
137(24), 5792–802 (2012).

93.

Chernenko T, Sawant RR, Miljkovic M, Quintero L, Diem M, Torchilin V. Raman microscopy for
noninvasive imaging of pharmaceutical nanocarriers: intracellular distribution of cationic
liposomes of different composition. Molecular pharmaceutics . 9(4), 930–6 (2012).

94.

Miljković M, Chernenko T, Romeo MJ, Bird B, Matthäus C, Diem M. Label-free imaging of human
cells: algorithms for image reconstruction of Raman hyperspectral datasets. Analyst . 135(8),
2002–13 (2010).

95.

Zheltikov AM. Coherent anti-Stokes Raman scattering: from proof-of-the-principle experiments
to femtosecond CARS and higher order wave-mixing generalizations. Journal of Raman
Spectroscopy. 667(January), 653–667 (2000).

96.

Pezacki JP, Blake J a, Danielson DC, Kennedy DC, Lyn RK, Singaravelu R. Chemical contrast for
imaging living systems: molecular vibrations drive CARS microscopy. Nature chemical biology .
7(3), 137–45 (2011).

97.

Wang H, Langohr I. Imaging and quantitative analysis of atherosclerotic lesions by CARS-based
multimodal nonlinear optical microscopy. Arterioscler Thromb Vasc Biol . 29(9), 1342–1348
(2009).

98.

Nan X, Potma EO, Xie XS. Nonperturbative chemical imaging of organelle transport in living cells
with coherent anti-stokes Raman scattering microscopy. Biophysical journal . 91(2), 728–35
(2006).

99.

Lalatsa a, Garrett NL, Ferrarelli T, Moger J, Schätzlein a G, Uchegbu IF. Delivery of peptides to the
blood and brain after oral uptake of quaternary ammonium palmitoyl glycol chitosan
nanoparticles. Molecular pharmaceutics . 9(6), 1764–74 (2012).

100.

Le TT, Huff TB, Cheng J-X. Coherent anti-Stokes Raman scattering imaging of lipids in cancer
metastasis. BMC cancer . 9, 42 (2009).

101.

Le TT, Duren HM, Slipchenko MN, Hu C-D, Cheng J-X. Label-free quantitative analysis of lipid
metabolism in living Caenorhabditis elegans. Journal of lipid research . 51(3), 672–7 (2010).

102.

Wang H, Fu Y, Zickmund P, Shi R, Cheng J-X. Coherent anti-stokes Raman scattering imaging of
axonal myelin in live spinal tissues. Biophysical journal . 89(1), 581–91 (2005).

103.

Fu Y, Huff T, Wang H, Cheng J, Wang H. Ex vivo and in vivo imaging of myelin fibers in mouse
brain by coherent anti-Stokes Raman scattering microscopy. Optics express . 16(24), 19396–
19409 (2008).

104.

Tong L, Lu Y, Lee RJ, Cheng J-X. Imaging receptor-mediated endocytosis with a polymeric
nanoparticle-based coherent anti-stokes Raman scattering probe. The journal of physical
chemistry. B . 111(33), 9980–5 (2007).

105.

Osborne OJ, Johnston BD, Moger J, et al. Effects of particle size and coating on nanoscale Ag and
TiO(2) exposure in zebrafish (Danio rerio) embryos. Nanotoxicology . (October), 1–10 (2012).

106.

Moger J, Johnston BD, Tyler CR. Imaging metal oxide nanoparticles in biological structures with
CARS microscopy. Optics express . 16(5), 3408–19 (2008).

107.

Garrett NL, Lalatsa A, Uchegbu I, Schätzlein A, Moger J. Exploring uptake mechanisms of oral
nanomedicines using multimodal nonlinear optical microscopy. Journal of biophotonics . 5(5-6),
458–68 (2012).

(**) The potential of a multimodel label free imaging technique incorporating CARS is demonstrated in
the identification of oral nano drug carriers
108.

Koo T-W, Chan S, Berlin A a. Single-molecule detection of biomolecules by surface-enhanced
coherent anti-Stokes Raman scattering. Optics letters . 30(9), 1024–6 (2005).

109.

Schlücker S, Salehi M, Bergner G, et al. Immuno-surface-enhanced coherent anti-stokes Raman
scattering microscopy: immunohistochemistry with target-specific metallic nanoprobes and
nonlinear Raman microscopy. Analytical chemistry . 83(18), 7081–5 (2011).

110.

Drescher D, Kneipp J. Nanomaterials in complex biological systems: insights from Raman
spectroscopy. Chemical Society reviews . 41(17), 5780–99 (2012).

111.

Monopoli MP, Aberg C, Salvati A, Dawson K a. Biomolecular coronas provide the biological
identity of nanosized materials. Nature nanotechnology. 7(12), 779–86 (2012).

112.

Nawaz H, Bonnier F, Knief P, et al. Evaluation of the potential of Raman microspectroscopy for
prediction of chemotherapeutic response to cisplatin in lung adenocarcinoma. Analyst . 135(12),
3070–6 (2010).

113.

Nawaz H, Bonnier F, Meade AD, Lyng FM, Byrne HJ. Comparison of subcellular responses for the
evaluation and prediction of the chemotherapeutic response to cisplatin in lung adenocarcinoma
using Raman spectroscopy. Analyst . 136(12), 2450–63 (2011).

114.

Klein K, Gigler AM, Aschenbrenner T, et al. Label-free live-cell imaging with confocal Raman
microscopy. Biophysical journal . 102(2), 360–8 (2012).

115.

Almond M, Hutchings J, Kendall C, et al. Towards real-time “biochemical endoscopy” for
diagnosis of early barrett’s neoplasia. Gut. 60, 167–168 (2011).

101.

http://www.invitrogen.com/site/us/en/home/support/Research-Tools/Cell-Staining-Tool.html

102. http://www.invitrogen.com/site/us/en/home/brands/Molecular-Probes/Key-Molecular-ProbesProducts/Qdot.html

